Genetic and epigenetic profile of sporadic pheochromocytomas.

作者信息

Cascon A, Ruiz-Llorente S, Fraga M F, Leton R, Telleria D, Sastre J, Diez J Jose, Martinez Diaz-Guerra G, Diaz Perez J A, Benitez J, Esteller M, Robledo M

机构信息

Hereditary Endocrine Cancer Group, Department of Human Genetics, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain.

出版信息

J Med Genet. 2004 Mar;41(3):e30. doi: 10.1136/jmg.2003.012658.

DOI:10.1136/jmg.2003.012658

PMID:14985401

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1735704/

Abstract

摘要

相似文献

[1]

Genetic and epigenetic profile of sporadic pheochromocytomas.

J Med Genet. 2004-3

[2]

Intronic single nucleotide polymorphisms in the RET protooncogene are associated with a subset of apparently sporadic pheochromocytoma and may modulate age of onset.

J Clin Endocrinol Metab. 2003-10

[3]

Localizing a putative mutation as the major contributor to the development of sporadic Hirschsprung disease to the RET genomic sequence between the promoter region and exon 2.

Eur J Hum Genet. 2004-8

[4]

Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.

Fam Cancer. 2005

[5]

Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2.

J Clin Endocrinol Metab. 2005-7

[6]

RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.

Oncogene. 2001-11-8

[7]

The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.

Gastroenterology. 2007-1

[8]

Sequence variant in the intron 10 of the RET oncogene in a patient with microfollicular thyroid carcinoma with medullar differentiation: implications for newly generated chi-like sequence.

Med Oncol. 2004

[9]

Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics.

Mol Carcinog. 2015-12

[10]

Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.

Int J Mol Med. 2004-10

引用本文的文献

[1]

Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing.

Clin Biochem Rev. 2017-4

[2]

ARHI is a novel epigenetic silenced tumor suppressor in sporadic pheochromocytoma.

Oncotarget. 2017-9-21

[3]

Genetic and epigenetic patterns in patients with the head-and-neck paragangliomas associate with differential clinical characteristics.

J Cancer Res Clin Oncol. 2017-6

[4]

Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis.

Int J Endocrinol. 2015

[5]

Pituitary adenoma with paraganglioma/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice.

J Clin Endocrinol Metab. 2015-5

[6]

Paragangliomas/Pheochromocytomas: clinically oriented genetic testing.

Int J Endocrinol. 2014

[7]

The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas.

Epigenetics. 2013-10-22

[8]

Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation.

Endocr Relat Cancer. 2013-2-18

[9]

Somatic mutation analysis of the SDHB, SDHC, SDHD, and RET genes in the clinical assessment of sporadic and hereditary pheochromocytoma.

Horm Cancer. 2012-5-10

[10]

Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.

Cancer Genet. 2012

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Genetic and epigenetic profile of sporadic pheochromocytomas.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献